Recent Posts on This Topic | See All >
[Source: University of Arizona Communications] - Turmeric – the key ingredient in curry – has been used in India for thousands of years to help treat colds, inflammation, arthritis and even cancer.
Now, researchers at the Steele Children’s Research Center at The University of Arizona have found that curcumin (the biologically active ingredient in turmeric) may be a viable supplement to treat Inflammatory Bowel Disease (IBD). Basically, they have shown that curcumin decreases the severe inflammation and resultant intestinal damage caused by IBD.
IBD refers to two inflammatory diseases: Crohn’s Disease, which affects the entire gastrointestinal tract, and ulcerative colitis, which affects the colon. Both cause severe abdominal pain, diarrhea, vomiting, fatigue and weight loss. As many as one in 500 individuals will be diagnosed with IBD each year, and IBD typically is diagnosed in children and young adults between the ages of 10 and 19. Approximately 1 million individuals in the United States suffer from IBD.
Now available: “Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is now available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” An overview by Walter Plosila, Ph.D., Battelle senior advisor, is also available. The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade.